Synlett 1998; 1998(4): 428-430
DOI: 10.1055/s-1998-3131
letter
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Preparation of Phospho-l-Azatyrosine Suitably Protected for the Synthesis of Signal Transduction Related Peptides. A Correction

Zhu-Jun Yao* , Bin Ye, Kengo Miyoshi, Akira Otaka, Terrence R. Burke, Jr.
  • *Laboratory of Medicinal Chemistry, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Building 37, Room 5C06, Bethesda, Maryland 20892, U.S.A.; Fax + 301-402-22 75; E-mail: tburke@helix.nih.gov
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Synthesis of Nα-Fmoc 4-O,O-(di-tert-butyl)phospho-L-azatyrosine (6) and its use in Fmoc-based solid-phase peptide synthesis are reported. The di-tert-butyl phospho protecting groups were removed during TFA-mediated cleavage of the finished peptide (10) from the resin, providing the free phosphoazatyrosine-containing peptide directly. This is in contrast to diethyl phospho protection we previously reported [Ye, B.; Otaka, A.; Burke, T. R., Jr. Synlett 1996, 459-460] in which the diethyl protection has proven impractical to remove. Due to incorrect assignment of starting material, the title compound of this latter report should be corrected to the isomeric L-β-(3-hydroxy-2-pyridyl)-alanine compound (5).

    >